DFDA

Ceftriaxone

Treatment for Paratyphoid Fever

Typical Dosage: 1-2 g intravenously or intramuscularly once daily

Effectiveness
90%
Safety Score
70%
Clinical Trials
30
Participants
6K

Comparative Safety Scale(Higher is safer)

Cyanideâ˜ ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
1-2 g intravenously or intramuscularly once daily
Time to Effect
12-24 hours
Treatment Duration
10-14 days
Evidence Quality
HIGH
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$400
Side Effect Mgmt:$10
Total Annual:$910
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
Outcome-Based Costs
Cost per Responder
$957.89
Cost per Remission
$989.13
Prescription Access Economics
Physician Visit Cost
$150/year
Time Cost
$200/year
Travel + wait time
Insurance Admin Cost
$25/year
Prior auth, claims
Rx Price
$500/year
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
HIGH
Ceftriaxone Outcomes

for Paratyphoid Fever

Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+95%
Remission Rate
+92%
Common Side Effects
Diarrhea
+4%
Rash
+2%
Injection site pain
+2%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov